Prince Street Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Prince Street Capital Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,390	Closed	-$920K	–	39
2018 Q4	$920K	Sell	6,390 -11,391	-64%	-$2.55M	0.23%	38
2018 Q3	$5.68M	Hold	17,781	–	–	1.2%	21
2018 Q2	$6.33M	Buy	+17,781	New	+$5.51M	1.3%	17

Other funds holding ASLN

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Prince Street Capital Management's ASLN Position: Q1 2019 in Review

Prince Street Capital Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2019, closing a stake of 6,390 shares — an estimated $920K sold.

Prince Street Capital Management first reported a position in ASLN in Q2 2018 and held it in 3 quarters. The position peaked at $6.33M in Q2 2018. 8 funds tracked by Wall St. Rank hold ASLN as of Q1 2019.

Prince Street Capital Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Prince Street Capital Management sold 6,390 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2019, an estimated $920K.
Prince Street Capital Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2018 and held it in 3 quarters.
Prince Street Capital Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $6.33M in Q2 2018.
8 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2019.

Based on Prince Street Capital Management's 13F filing for Q1 2019, filed 15 May 2019.